- Previous consulting experience focused on analyzing R&D, orphan drug expenditure, and cost segregation
- Cross industry experience designing and implementing financial modeling systems
Noah is an Investment Analyst at Foresite Capital, where he is responsible for modeling, research, and leveraging technology to enhance this process. Previously, he served as a manager in the Professional Services organization at Anaplan, following his time as an R&D, orphan drug, and cost segregation consultant in the Big 4. Noah earned his bachelor's degree at the University of California at Davis, and an MSE from North Dakota State University.